Search
for
Sort by
Research 241–270 of 250
- 1,314
- Referee report. For: Practices, awareness, and perception towards home-based COVID-19 management among the general population in Mangalore city in south India [version 2; peer review: 1 approved, 1 approved with reservations]
- Referee report. For: Practices, awareness, and perception towards home-based COVID-19 management among the general population in Mangalore city in south India [version 2; peer review: 2 approved]
- The use of NDYAG laser combined with pulsed light in the treatment of rosacea
- Mite Burden and Immunophenotypic Response to <i>Demodex musculi</i> in Swiss Webster, BALB/c, C57BL/6, and NSG Mice
- ZALCITABINE
- Essential Oils and Their Individual Components in Cosmetic Products
- Identification of a Cyclosporine-Specific P450 Hydroxylase Gene through Targeted Cytochrome P450 Complement (CYPome) Disruption in Sebekia benihana
- The Influence of Allium cepa Extracts on Promotion of Hair Growth
- Alopecia in Belgian Blue crossbred calves: a case series
- Mechanisms of ivermectin-induced wound healing
- EVALUATION OF IVERMECTIN FOR TREATMENT OF HAIR LOSS SYNDROME IN BLACK-TAILED DEER
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Scalp Rosacea Treated with Topical Ivermectin
- TREATMENT OF SCABIES AND CUTANEOUS SPOROTRICHOSIS IN DOMESTIC CATS USING IVERMECTIN AND SULFUR
- TRICHOGRAM OBSERVATION OF ORAL IVERMECTIN THERAPY IN SCABIOSIS AND OTITIS EXTERNA IN DOMESTIC CATS
- USE OF IVERMECTINE AS TOPICAL APPLICATION IN TREATMENT OF RABBIT MANGE
- Preparation and Physicochemical Evaluation of Topical Cream Ivermectin 1% for Treatment of Rosacea
- 158 Novel effects of ivermectin in rosacea: reduction of erythema, flushing, skin texture, and invisible symptoms
- Oral ivermectin in the treatment of scabies
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- COVID‐19 and dermatology: a comprehensive guide for dermatologists
- Demodex folliculitis
- Comparison of the efficacy of tea tree (<i>Melaleuca alternifolia</i>) oil with other current pharmacological management in human demodicosis: A Systematic Review
- AN UNDESCRIBED DEMODEX SP. AND DEMODICOSIS IN A CAPTIVE KOALA (PHASCOLARCTOS CINEREUS)
- Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 <i>in vitro</i> infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19
- First Infestation Case of Sarcoptic Mange from a Pet Rabbit Oryctolagus Cuniculus in Republic of Korea